Raymond James & Associates’s Kyndryl KD Stock Holding History

Raymond James & Associates’s Portfolio KD Stock Details KD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$745K	Buy	32,409 +17	+0.1%	+$415	﹤0.01%	2872
2024 Q2	$852K	Sell	32,392 -12,014	-27%	-$288K	﹤0.01%	2737
2024 Q1	$966K	Sell	44,406 -8,984	-17%	-$191K	﹤0.01%	2616
2023 Q4	$1.11M	Sell	53,390 -36,159	-40%	-$618K	﹤0.01%	2456
2023 Q3	$1.35M	Sell	89,549 -3,385	-4%	-$50.2K	﹤0.01%	2262
2023 Q2	$1.23M	Buy	92,934 +1,213	+1%	+$16.4K	﹤0.01%	2353
2023 Q1	$1.35M	Sell	91,721 -9,777	-10%	-$139K	﹤0.01%	2268
2022 Q4	$1.13M	Sell	101,498 -14,130	-12%	-$142K	﹤0.01%	2357
2022 Q3	$956K	Sell	115,628 -7,243	-6%	-$75.3K	﹤0.01%	2425
2022 Q2	$1.2M	Sell	122,871 -16,704	-12%	-$194K	﹤0.01%	2320
2022 Q1	$1.83M	Sell	139,575 -20,462	-13%	-$308K	﹤0.01%	2190
2021 Q4	$2.9M	Buy	+160,037	New	+$3.45M	﹤0.01%	1911

Other funds holding KD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James & Associates's KD Position: Q3 2024 in Review

Raymond James & Associates increased its Kyndryl (KD) stake by 0.05% in Q3 2024, buying an estimated $415 and bringing the position to 32,409 shares worth $745K. The position accounts for ﹤0.01% of the portfolio, ranked #2872.

Raymond James & Associates first reported a position in KD in Q4 2021 and has held it in 12 quarters since. The position peaked at $2.9M in Q4 2021. 626 funds tracked by Wall St. Rank hold KD as of Q3 2024.

Raymond James & Associates held 32,409 shares of Kyndryl worth $745K as of Q3 2024.
Raymond James & Associates bought 17 Kyndryl shares in Q3 2024, an estimated $415.
Kyndryl made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2872 holding.
Raymond James & Associates first reported a position in Kyndryl in Q4 2021 and has held it in 12 quarters since.
Raymond James & Associates's Kyndryl position peaked at $2.9M in Q4 2021.
626 funds tracked by Wall St. Rank held Kyndryl as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.